WithdrawnNCT00811863

Evaluation of Nephrogenic Systemic Fibrosis (NSF) in Patients With Chronic Kidney Disease Following OptiMARK Injection

Studying Nephrogenic systemic fibrosis

Last synced from ClinicalTrials.gov May 13, 2026

ℹ

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.

Report missing data

Key facts

Sponsor: Guerbet
Principal Investigator: Herbert R. Neuman, MD
Mallinckrodt
Eligibility: All sexes
Timeline: 2009 – 2012

Study locations (1)

Radiology Consultants, Inc., Youngstown, Ohio, United States

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT00811863 on ClinicalTrials.gov

← Back to all trials